Introduction to the special issue on the HEALing Communities Study

Nabila El-Bassel, Rebecca D Jackson, Jeffrey Samet, Sharon L Walsh, Nabila El-Bassel, Rebecca D Jackson, Jeffrey Samet, Sharon L Walsh

Abstract

The severity of the overdose epidemic underscores the urgent need for innovative and high impact interventions that promote the rapid penetration and scale up of evidence-based practices (EBPs) in communities profoundly affected by fatal opioid overdose. This special issue shares scientific advancements in implementation research design and evaluation of a novel data-driven community-based intervention. The HEALing (Helping End Addiction Long-Term) Communities Study (HCS) is a four-year study that is designed to examine the effectiveness of the Communities That HEAL (CTH) intervention. The CTH intervention supports the dissemination of EBPs in 67 communities across four high-burdened states-Kentucky, Massachusetts, New York, and Ohio. The diversity in these communities in terms of rural-urban status, race-ethnicity and other social determinants of health facilitates generalizability of results to other communities across the US. The nine papers in this special issue describe critical elements that constitute the HCS framework and design. This includes the implementation of EBPs that have a substantial impact on fatal and non-fatal opioid overdose, the Opioid-overdose Reduction Continuum of Care Approach, communication campaigns to increase awareness and demand for EBPs and reduce stigma against people with OUD and MOUD interventions, and the process of community engagement. This includes how to form community coalitions and gain their commitment, and steps taken to mobilize coalitions to pursue EBP implementation and ensure EBPs are adapted for community needs. The collective papers in this issue demonstrate that the design of any complex study must adapt to unanticipated temporal events, including the rapidly emerging COVID-19 crisis. Readers will learn about the scientific process of the design and implementation of a community-engaged intervention, its methodologies, guiding conceptual models, and research implementation strategies that can be applied to address other health issues.

Trial registration: ClinicalTrials.gov NCT04111939.

Keywords: HEALing Communities Study; Helping to End Addiction Long-Term; evidence-based practice; implementation science; intervention; opioid use disorder.

Conflict of interest statement

The authors report no declarations of interest.

Copyright © 2020. Published by Elsevier B.V.

References

    1. Aldridge A., Zarkin G., Villani J., McCollister K., Barocas J., Schackman B., Hyder A., Barbosa C., Chatwal J., Bush J., Linas B., Starbird L., Seiber E., Harlow K. Health economic design for cost, cost-effectiveness and simulation analyses in the Healing Communities Study. Drug Alcohol Depend. 2020;217 doi: 10.1016/j.drugalcdep.2020.108336. 108336.
    1. American Medical Association . 2020. Issue Brief: Reports of Increases in Opioid-Related Overdose During COVID Pandemic. Available at increases-in-opioid-related-overdose.pdf. (Accessed: August 16, 2020)
    1. Centers for Disease Control and Prevention, National Center for Health Statistics . 2020. Underlying Cause of Death 1999-2018 on CDC WONDER Online Database, Released 2020. Data are From the Multiple Cause of Death Files, 1999–2017, as Compiled From Data Provided by the 57 Vital Statistics Jurisdictions Through the Vital Statistics Cooperative Program. Available at . (Accessed August 16, 2020)
    1. Chandler R., VIllani J., Clark T., Volkow N. The HEALing Communities Study: a vision for addressing the opioid crisis. Drug Alcohol Depend. 2020;217 doi: 10.1016/j.drugalcdep.2020.108329. 108329.
    1. Collins A.B., Ndoye C.D., Arene- Morley D., Marshall B.D.L. Addressing co-occurring public health emergencies: the importance of naloxone distribution in the era of COVID-19. Int. J. Drug Policy. 2020 doi: 10.1016/j.drugpo.2020.102872.
    1. Jenkins W.D., Bolinski R., Bresett J., Van Ham B., Fletcher S., Walters S., Friedman S.R., Ezell J.M., Pho M., Schneider J. COVID-19 during the opioid epidemic-exacerbation of stigma and vulnerabilities. J. Rural Health. 2020 doi: 10.1111/jrh.12442.
    1. Knudsen H., Drainoni M., Gilbert L., Huertad T., Oser C., Aldrich A., Campbell A., Crable E., Garner B., Glasgow L., Goddard- Eckrich D., Marks K., McAlearney A., Oga E., Scalise A., Walker D. Model and approach to assessing implementation context and fidelity in the HEALing Communities Study. Drug Alcohol Depend. 2020;217 doi: 10.1016/j.drugalcdep.2020.108330. 108330.
    1. Lefebrve C., Helme D., Stein M., Kerner R., Slater M., Reynolds J., Chandler R., Roeber C., Beard D., Rodgers E., Shadwick A., Burrus O. Health communication campaigns to drive demand for evidence- based practices and reduce stigma in the HEALing Communities Study. Drug Alcohol Depend. 2020;217 doi: 10.1016/j.drugalcdep.2020.108338. 108338.
    1. Martinez L., Rapkin B., Young A., Freisthler B., Glasgow L., Hunt T., Salsberry P., Oga E., Bennet- Fallin A., Plouk T., Drainoni M., Freeman P., Gulley J., Hamilton G., Bowman P., Roeber C., El- Bassel N., Battaglia T. Community engagement to implement evidence-based practices in the HEALing Communities Study. Drug Alcohol Depend. 2020;217 doi: 10.1016/j.drugalcdep.2020.108326. 108326.
    1. Slavova S., LaRochelle M., Root E., Feaster D., Villani J., Knott C., Talbert J., Mack A., Crane D., Bernson D., Booth A., Walsh S. Operationalizing and selecting outcome measures in the HEALing communities study. Drug Alcohol Depend. 2020;217 doi: 10.1016/j.drugalcdep.2020.108328. 108328.
    1. Strang J., Volkow N.D., Degenhardt L., Hickman M., Johnson K., Koob G.F., Marshall B.D., Tyndall M., Walsh S.L. Opioid use disorder. Nat. Rev. Dis. Primers. 2020;6:1–28.
    1. The HEALing Communities Study Consortium The HEALing (Helping end addiction long-term) communities study: protocol for a cluster-randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices. Drug Alcohol Depend. 2020;217 doi: 10.1016/j.drugalcdep.2020.108335. 108335.
    1. Wilson N., Kariisa M., Seth P., Smith H., Davis N.L. Drug and opioid-involved overdose deaths—united States, 2017–2018. MMWR Morb. Mortal. Wkly. Rep. 2020;69
    1. Winhusen T., Walley A., Fanucchi L., Hunt T., Lyons M., Lofwall M., Brown J., Freeman P., Beers D., Saitz R., Stambaugh L., Oga E., Herron N., Baker T., Cook C., Roberts M., Alford D., Starels J., Chandler R. The opioid-overdose reduction continuum of care approach (ORCCA): evidence-based practices in the HEALing communities study. Drug Alcohol Depend. 2020;217 doi: 10.1016/j.drugalcdep.2020.108325. 108325.
    1. Wu E., Villani J., Davis A., Fareed N., Harris D., Huerta T., LaRochelle M., Miller C., Oga E. Community dashboards to support data-informed decision making in the HEALing Communities Study. Drug Alcohol Depend. 2020;217 doi: 10.1016/j.drugalcdep.2020.108331. 108331.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren